NCCN Guidelines for Patients® | Esophageal Cancer - page 98

98
NCCN Guidelines for Patients
®
: Esophageal Cancer
Version 1.2013
Index
Anxiety
82–83
Biopsy
15, 23–25, 29, 50–51, 71
Cancer staging
11–21
Caregivers
84,
86
Chemotherapy
33–36, 38, 40–50, 52–54, 57, 59–70,
72–78, 83–84
Clinical staging tests
12
Complementary and alternative medicine
36
Depression
82
Endoscopic treatments
29–30, 53, 74
Esophagectomy
30, 40–41, 43–48, 51–52, 57, 59–60,
62–64, 66–69, 71–73, 78
Esophagus
8, 10, 13, 15–18, 24, 29–32, 51, 63, 72
HER2
25, 35, 75
Lymph nodes
9, 13, 17, 24, 30, 43, 60–61, 63–64, 67
Member Institutions
96–97
National Comprehensive Cancer Network
4, 93
Nutrition
26
Panel Members
94–95
Pathology report
15, 86
Performance status
54, 74–75
Radiation therapy
33–34, 50, 53, 70, 74
Risk factors
12–13
Side effects
34, 36
Sleep
82
Survivorship
83
Supportive care
53–56, 74–77
Targeted therapy
35–36
Treatment options
39–78
Treatment planning
79–87
Treatment team
25–26, 33–34, 36, 53, 74, 80, 82–84
1...,88,89,90,91,92,93,94,95,96,97 99,100
Powered by FlippingBook